Skip to content
healthcare.dev

Olanzapine

NDC 0517-0955, Olanzapine, injection, powder, lyophilized, for solution, from American Regent, Inc..

Product NDC
0517-0955
Status
Listed
Labeler
American Regent, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201741
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0517-0955 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE10 mg/2mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
0517-0955-01005170955011 VIAL, GLASS in 1 CARTON (0517-0955-01) / 2 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0517-0955
  • NADAC price for package 00517095501

    GET /v1/drugs/nadac/00517095501

Use it

Look up 0517-0955 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0517-0955 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0517-0955. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.